Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annie Yang Weaver"'
Autor:
Sarah Cohen, Jacob Waldman, Andrew Dunn, Thao Nguyen, Jonathan Terrett, Brigid Mcewan, Meghna Kuppuraju, Mohammed Ghonime, Robert Chain, Zinkal Padalia, Demetrios Kalaitzidis, Elizabeth Koch, Lauren Zakas, Nivedita Jaishankar, Davis Settipane, Paul Tetteh, Mary-Lee Dequeant, Sushant Karnik, Chandirasegaran Massilamany, Henia Dar, Melanie Allen, Laura Serwer, Melanie Butler-Gauthier, Parin Sripakdeevong, Shashwat Nagar, Yin Tang, Nicole Flanagan, Elaine Huang, Shashwant Phuyal, Erisa Sula, Maria Lei Zhang, Cristian Loaiza, Erin Thorstensen, Keith Steiger, Katie Schum, Kayla Urbaez, Anna Ma, Annie Yang Weaver, Christopher Finch, PK Morrow, Mark Benton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/796a7e13bcf54ab3a8c543bff6cb2654
Autor:
Joel Shen, Jennifer Richardson, Bob Y. Liu, Siew Schleyer, Annie Yang Weaver, Matthias Will, Sreeni Yalamanchili, Michael P. Kavanaugh, Marcia Belvin, Judi Gordon, Luc Desnoyer, Mark Stroh
Publikováno v:
Cancer Research. 79:212-212
Ideal targets for antibody drug conjugates (ADC) are highly and homogeneously expressed on tumor cells in a wide variety of tumor types and in a high proportion of patients. Such targets should also be efficient cellular internalizers and have limite
Autor:
Luc Desnoyers, Yuanhui Huang, Shouchun Liu, Annie Yang Weaver, Shweta Singh, Linnea Diep, Kim Tipton, Jonathan Alexander Terrett, Clayton White, Jennifer Richardson, Amy DuPage, W. Michael Kavanaugh, Michael Krimm, Jason Gary Sagert
Publikováno v:
Cancer Research. 76:2975-2975
The targets of Antibody Drug Conjugates (ADCs) have typically been selected by identifying transmembrane antigens that are highly expressed in tumors but are low or absent in normal tissues. The number of potential ADC targets meeting these requireme
Autor:
Luc Desnoyers, Yuanhui Huang, Andrew Jang, Elizabeth Menendez, Jason Gary Sagert, Shouchun Liu, Eric Brecht, Olga Vasiljeva, Margaret Nguyen, Nicole Lapuyade, James W. West, Michael Krimm, Annie Yang Weaver, Jeanne Grace Flandez, Stephen R. Moore, Judi Ford, W. Michael Kavanaugh, Linnea Diep, Tereza Sputova, Jonathan A. Terrett, Shweta Singh, Amy DuPage, Jennifer Richardson
Publikováno v:
Molecular Cancer Therapeutics. 14:C165-C165
Antibody drug conjugates (ADCs) have shown their greatest clinical utility when targeting antigens expressed at very high levels on cancer cells that have coincidentally lower expression in normal tissues. This is exemplified by the approvals of tras